References
- Blombäck B., Blombäck M. Purification of human and bovine fibrinogen. Ark. Kemi 1956; 10: 415
- Cliffton E. E. Early experience with fibrinolysin. Angiology 1959; 10: 244
- Fletcher A. P., Alkjaersig N., Sherry S. The maintenance of a sustained thrombolytic state in man. I. Induction and effect's. J. clin. Invest. 1959; 38: 1096
- Kline D. L. Purification and crystallization of plasminogen (profibrinolysin). J. biol. Chem. 1953; 204: 949
- Nilson I. M., Blombäck M., Francken I. On an inherited autosomal hemorrhagic diathesis with antihemophilic globulin (AHG) deficiency and prolonged bleeding time. Acta med. scand. 1957; 159: 35
- Nilsson I. M., Krook H., Stennby N.-H., Söderberg E., Söderströim N. Severe thrombotic disease in a young man with bone marrow and skeletal changes and with a high content of an inhibitor in the fibrinolytic system. Acta med. scand. 1961; 169: 323
- Nilsson I. M., Sjoerdsma A., Waldenström J. Antifibrinolytic activity and metabolism of E-aminocaproic acid in man. Lancet 1960; 1: 1322
- Oneley J. L. The separation af the antibodies isoagglutinins prothrombin, plasminogen, and β1 into subfractions of human plasma. J. Amer. Chem. Soc. 1949; 71: 541
- Tillett W. S., Johnson A. J., McCarty W. R. Intravenous infusion of the streptococcal fibrinolytic principle (streptokinase) into patients. J. clin. Invest. 1955; 34: 169